Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	430.47	711.59	775.47	854.69	589.3	602.55
Short-Term Investments	362.72	250	90	107.1	227.37	76.79
Cash & Short-Term Investments	793.19	961.59	865.47	961.79	816.67	679.34
Cash Growth	-34.84%	11.11%	-10.02%	17.77%	20.21%	-25.31%
Accounts Receivable	2.64	2.21	2.54	2.55	1.94	3.72
Other Receivables	0.87	0.72	26.07	6.84	1.37	4.71
Receivables	3.51	2.93	28.61	9.39	3.3	8.43
Inventory	192.38	152.66	157.36	93.67	73.79	54.74
Other Current Assets	42.02	25.9	41.08	14.08	11.81	45.06
Total Current Assets	1,031	1,143	1,093	1,079	905.58	787.57
Property, Plant & Equipment	896.03	911.64	939.2	904.32	604.39	485.56
Long-Term Investments	-	-	-	-	10.3	17.18
Other Intangible Assets	8.07	9.75	6.4	5.06	3.84	3.84
Long-Term Deferred Tax Assets	34.33	28.89	37.71	53.39	20.76	17.32
Other Long-Term Assets	31.86	30	19.15	117.33	248.41	172.55
Total Assets	2,001	2,123	2,095	2,159	1,793	1,484

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	20.8	7.25	18.27	11.98	21.77	14.95
Current Portion of Leases	34.49	25.47	23.28	24.24	13.27	32.28
Current Income Taxes Payable	128.4	72.08	67.76	89.03	82.94	70.84
Current Unearned Revenue	48.58	22.05	73.85	202.57	60.09	122.95
Other Current Liabilities	172.08	166.91	145.75	129.62	147.93	92.93
Total Current Liabilities	404.36	293.76	328.91	457.43	326	333.95
Long-Term Leases	73.87	93.87	121.94	144.78	49.82	66.9
Long-Term Deferred Tax Liabilities	64.31	91.02	103.06	105.19	57.16	22.16
Other Long-Term Liabilities	27.89	26.95	28.23	25.59	35.02	37.43
Total Liabilities	570.43	505.6	582.13	732.99	468	460.44

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	544.63	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	3.65	3.65	25.44
Retained Earnings	872.1	1,067	973.11	892.8	778.61	460.46
Comprehensive Income & Other	10.55	2.39	-8.56	-15.04	-1.62	-6.95
Shareholders' Equity	1,431	1,618	1,513	1,426	1,325	1,024
Total Liabilities & Equity	2,001	2,123	2,095	2,159	1,793	1,484

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	108.37	119.33	145.21	169.02	63.09	99.18
Net Cash (Debt)	684.82	842.26	720.26	792.78	753.58	580.16
Net Cash Growth	-37.11%	16.94%	-9.15%	5.20%	29.89%	-25.59%
Net Cash Per Share	12.55	15.44	13.21	14.54	13.82	10.64
Filing Date Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Working Capital	626.73	849.33	763.6	621.51	579.57	453.62
Book Value Per Share	26.27	29.70	27.78	26.18	24.33	18.79
Tangible Book Value	1,423	1,608	1,506	1,421	1,321	1,020
Tangible Book Value Per Share	26.13	29.52	27.66	26.09	24.26	18.72
Land	64.9	64.9	64.9	-	-	-
Buildings	522.07	522.47	517.01	487.13	482.71	-
Machinery	345.95	343.9	343.25	293.4	82.42	62.95
Construction In Progress	5.73	3.99	0.3	17.79	-	331.26
Leasehold Improvements	43.87	23.46	45.44	44.01	44.79	44.4

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error